Dopamine News and Research

Latest Dopamine News and Research

Neuroscientists track gene expression to gain insights into drug addiction, Parkinson's disease

Two MIT neuroscientists have received grants from the G. Harold and Leila Y. Mathers Foundation to screen for genes that could help brain cells withstand Parkinson's disease and to map how gene expression changes in the brain in response to drugs of abuse.

4 Jan 2021

Phase 2 clinical trial at UCR to test first-in-class drug for treatment of stuttering

The School of Medicine at the University of California, Riverside, will serve as lead site for a Phase 2 clinical trial evaluating ecopipam, an investigational first-in-class drug being tested for the treatment of stuttering in adults and Tourette syndrome in pediatric patients.

15 Dec 2020

Economic activity can actively change the brain, shows study

Researchers at the HSE Institute for Cognitive Neuroscience have shown experimentally that economic activity can actively change the brain.

15 Dec 2020

Tomatoes could become a new, natural source of Parkinson's disease drug

Scientists have produced a tomato enriched in the Parkinson's disease drug L-DOPA in what could become a new, affordable source of one of the world's essential medicines.

9 Dec 2020

Researchers identify potential drug target that may improve cognition in people with mental illnesses

More than a dozen drugs are known to treat symptoms such as hallucinations, erratic behaviors, disordered thinking and emotional extremes associated with schizophrenia, bipolar disorder and other severe mental illnesses.

3 Dec 2020

Normal sleep depends on bacteria in the gut

With fall and winter holidays coming up, many will be pondering the relationship between food and sleep.

27 Nov 2020

Anti-diabetic drug could be repurposed for treating Parkinson's disease

A hallmark of Parkinson's disease is the degeneration of a group of dopaminergic neurons in the brain, which play key roles in movement initiation and co-ordination.

24 Nov 2020

Dopamine-release mechanisms in the brain may play a major role in SARS-CoV-2 infection

The study, which appeared in the Journal of Taibah University Medical Sciences, shows that the SARS-CoV-2 may behave akin to the CNS pathogenic mechanism of JEV and HIV during the early stages of infection.

15 Nov 2020

Return of mice to home cage evokes significant rise in dopamine release, shows study

By monitoring a well-replicated biomarker associated with reward, a study by neuroscientists from Florida Atlantic University provides evidence that the old adage, "There's no place like home," has its roots deep in the brain.

12 Nov 2020

Imaging technique reveals opioid receptor localization across the whole brain

Winding and twisting like a labyrinth, the brain consists of an elaborate network of passages through which information flows at high speeds, rapidly generating thoughts, emotions, and physical responses.

12 Nov 2020

Targeting TAAR5 can provide a new treatment opportunity for neurodegenerative disorders

St Petersburg University researchers, led by Professor Raul R. Gainetdinov, Director of the Institute of Translational Biomedicine and Academic Supervisor of the St Petersburg University Hospital, have found a new role for recently discovered neurotransmitter system that uses the trace amine-associated receptor 5 (TAAR5) for neurotransmission.

11 Nov 2020

Bioconductive, neuron-growing ink offers hope for people with nerve injury

Researchers have developed a neuron-growing ink that uses the body’s own electrical signals to precisely guide the growth of nerve cells.

10 Nov 2020

Addictive drug displays different acute pharmacology and synaptic plasticity

Nucleus accumbens in the brain play a central role in the risk-reward circuit. Their operation is based chiefly on three essential neurotransmitters: dopamine, which promotes desire; serotonin, whose effects include satiety and inhibition; and glutamate, which drives goal-directed behaviors and responses to reward-associated cues and contexts.

30 Oct 2020

DNase coated melanin-like nanospheres for sepsis treatment in severe COVID

As the treatment of severe COVID-19 is very difficult, the researchers from the Korea Research Institute of Biosciences and Biotechnology (KRIBB) suggested that DNase-1 can be utilized to dissolve the neutrophil extracellular traps (NETs), hence halting the further progression of COVID-19.

27 Oct 2020

Powerful drug used in chemotherapy could alleviate hallucinations in Parkinson's patients

A world-first double-blind clinical trial, will investigate if a powerful drug used to treat nausea in chemotherapy patients, could alleviate hallucinations in people with Parkinson's.

27 Oct 2020

Study examines the pharmacogenomics of opioid addiction

In one of the first studies of its kind, a University of Cincinnati researcher is using a grant from the Ohio attorney general's office to research the pharmacogenomics of opioid addiction.

13 Oct 2020

Two well-known neurochemicals found to be involved in sub-second perception, cognition

In first-of-their-kind observations in the human brain, an international team of researchers has revealed two well-known neurochemicals - dopamine and serotonin - are at work at sub-second speeds to shape how people perceive the world and take action based on their perception.

12 Oct 2020

Dopamine News and Research

Latest Dopamine News and Research

Neuroscientists track gene expression to gain insights into drug addiction, Parkinson's disease

Phase 2 clinical trial at UCR to test first-in-class drug for treatment of stuttering

Economic activity can actively change the brain, shows study

Tomatoes could become a new, natural source of Parkinson's disease drug

Researchers identify potential drug target that may improve cognition in people with mental illnesses

Normal sleep depends on bacteria in the gut

Anti-diabetic drug could be repurposed for treating Parkinson's disease

Dopamine-release mechanisms in the brain may play a major role in SARS-CoV-2 infection

Return of mice to home cage evokes significant rise in dopamine release, shows study

Imaging technique reveals opioid receptor localization across the whole brain

Targeting TAAR5 can provide a new treatment opportunity for neurodegenerative disorders

Bioconductive, neuron-growing ink offers hope for people with nerve injury

Addictive drug displays different acute pharmacology and synaptic plasticity

DNase coated melanin-like nanospheres for sepsis treatment in severe COVID

Powerful drug used in chemotherapy could alleviate hallucinations in Parkinson's patients

Study examines the pharmacogenomics of opioid addiction

Two well-known neurochemicals found to be involved in sub-second perception, cognition

Dopamine and serotonin play role in perception and decision-making

Gene variations that regulate dopamine levels in the brain may influence mobility of elderly, frail adults

Researchers elucidate the impact of genetic mutations in cocaine addiction

Quality, Patient Safety and Innovation Manager at Elsevier

How Bruker worked with the University of Manchester on mapping the dynamics of complex protein

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Dopamine News and Research

Latest Dopamine News and Research

Quality, Patient Safety and Innovation Manager at Elsevier

How Bruker worked with the University of Manchester on mapping the dynamics of complex protein

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Newsletters you may be interested in